Home > Boards > US Listed > Biotechs > Chembio Diagnostics (CEMI)

Repeating your post - this is interesting.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
XenaLives Member Profile
Member Level 
Followed By 367
Posts 49,108
Boards Moderated 28
Alias Born 09/20/01
160x600 placeholder
Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021 GlobeNewswire Inc. - 7/22/2021 5:03:53 PM
Chembio Diagnostics gets $4M HIV test purchase order Seeking Alpha - 7/22/2021 1:03:18 PM
Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund GlobeNewswire Inc. - 7/22/2021 12:49:39 PM
NeuroMetrix stock joins Reddit-driven rally with 60% rise in Q2 revenue Seeking Alpha - 7/22/2021 10:00:48 AM
Chembio Diagnostics Bags $28.3M Oder for SARS-CoV-2 Antigen Tests from Brazil TipRanks - 7/22/2021 2:53:30 AM
Chembio surges on purchase order for COVID—19 antigen test from Brazil Seeking Alpha - 7/21/2021 8:12:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2021 6:04:51 AM
Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil GlobeNewswire Inc. - 7/20/2021 10:56:14 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/19/2021 5:29:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 5:14:54 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/12/2021 8:30:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2021 5:21:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2021 4:06:31 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/13/2021 9:27:27 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/13/2021 9:26:04 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/7/2021 6:10:06 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 5:29:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 4:30:47 PM
Chembio Diagnostics EPS beats by $0.10, beats on revenue Seeking Alpha - 5/6/2021 4:28:28 PM
Chembio Diagnostics Reports First Quarter 2021 Financial Results GlobeNewswire Inc. - 5/6/2021 4:05:00 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2021 5:04:04 PM
Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021 GlobeNewswire Inc. - 4/22/2021 8:00:00 AM
Chembio announces U.S. launch of point-of-care-test to differentiate COVID-19 and Flu Seeking Alpha - 4/5/2021 10:28:43 AM
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu GlobeNewswire Inc. - 4/1/2021 5:30:00 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 3/15/2021 6:33:37 AM
XenaLives Member Level  Thursday, 10/08/20 10:20:33 AM
Re: keekee post# 323
Post # of 621 
Repeating your post - this is interesting.

PCR tests are unreliable, antibody tests tell more, but they are discoraged?

You seem to know a lot about this stock keekee, let's get a discussion on the fundamentals going.

So, THE FDA DID NOT STOP Rapid DPP COVID-19 tests. The FDA merely revoked EAuth. Now read what I will post below....the FDA three days go just out saying Healthcare Providers should continue using these tesk systems, but just be aware of its limitations. Read below: CAUTION...I AM LOADED HUGE!

"The FDA is not aware of an antibody test that has been validated for diagnosis of SARS-CoV-2 infection. While the FDA remains open to receiving submissions for these tests for such uses, based on the underlying scientific principles of antibody tests, the FDA does not expect that an antibody test can be shown to definitively diagnose or exclude SARS-CoV-2 infection.

The FDA recommends health care providers:

Continue to use serological (antibody) tests, as appropriate, and be aware of their limitations.
Do not use serological (antibody) tests as the sole basis to diagnose COVID-19 but instead as information about whether a person may have been exposed.
Be aware that not all marketed serological tests have been evaluated by the FDA. The FDA’s authorized tests, including serological tests, are listed on the Emergency Use Authorization (EUA) page. Tests being offered under a policy outlined in the FDA’s COVID-19 Diagnostic Policy Guidance are listed on our FAQ page. Such tests have not been reviewed by the FDA, unless an EUA has also been submitted and reviewed by FDA."


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences